Genmab A/S (GNMSF) News Today $330.00 -5.77 (-1.72%) As of 10/3/2025 11:39 AM Eastern Add Compare Share Share Headlines Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock GNMSF Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Genmab A/S (OTCMKTS:GNMSF) Sees Large Volume Increase - Still a Buy?October 3 at 8:13 PM | marketbeat.comHC Wainwright & Co. Maintains Genmab A (GMAB) Buy RecommendationOctober 3 at 5:05 AM | msn.comGenmab A/S (OTCMKTS:GNMSF) Shares Gap Up - Still a Buy?October 2, 2025 | marketbeat.comGenmab A/S (OTCMKTS:GNMSF) Reaches New 12-Month High - Time to Buy?October 1, 2025 | marketbeat.comMerus Stock Soars To All-Time High As Genmab Announces $8B Takeover — Analysts Turn Cautious, Retail Crowd Cheers The DealSeptember 30, 2025 | msn.comDenmark's Genmab Buys Dutch Cancer Drugmaker Merus For $8 BnSeptember 29, 2025 | barrons.comGenmab Agrees to Buy Cancer Drugmaker Merus for $8 BillionSeptember 29, 2025 | msn.comGenmab Is Said to Near Deal to Buy Cancer Drugmaker MerusSeptember 29, 2025 | msn.comMerus Buyout Rumor Gets Retail Traders Buzzing — Genmab Said To Be Leading The RaceSeptember 29, 2025 | msn.comGenmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned ModelSeptember 29, 2025 | markets.businessinsider.comGenmab A/S (OTCMKTS:GNMSF) Sets New 12-Month High - Here's WhySeptember 25, 2025 | marketbeat.comAnalyst Expectations For Genmab's FutureSeptember 24, 2025 | benzinga.comGenmab upgraded at Guggenheim; says Darzalex related growth concerns are overblownSeptember 23, 2025 | msn.comGenmab says Orbis holds 5.03% of share capitalSeptember 23, 2025 | msn.comGenmab A/S (OTCMKTS:GNMSF) Shares Gap Down - What's Next?September 19, 2025 | marketbeat.comGenmab A/S (OTCMKTS:GNMSF) Share Price Crosses Above 50 Day Moving Average - Should You Sell?September 19, 2025 | marketbeat.comBernstein Reiterates a Sell Rating on Genmab A/S (GMAB)September 19, 2025 | finance.yahoo.comBernstein Reiterates a Sell Rating on Genmab A/S (GMAB)September 17, 2025 | insidermonkey.comBernstein Reiterates a Sell Rating on Genmab A/S (GMAB)September 17, 2025 | msn.comGenmab A/S (OTCMKTS:GNMSF) Short Interest Up 148.7% in AugustSeptember 15, 2025 | marketbeat.comGenmab A/S (OTCMKTS:GNMSF) Sets New 52-Week High - Time to Buy?September 13, 2025 | marketbeat.comGenmab A/S (OTCMKTS:GNMSF) Stock Price Crosses Above Fifty Day Moving Average - Here's What HappenedSeptember 13, 2025 | marketbeat.comGenmab A/S (GMAB) Scores FDA Breakthrough for Rina-SSeptember 11, 2025 | msn.comGenmab A/S (OTCMKTS:GNMSF) Short Interest UpdateSeptember 10, 2025 | marketbeat.comGenmab A/S Updates Articles of Association to Boost Financial FlexibilitySeptember 10, 2025 | tipranks.comGenmab (CPSE:GMAB): Valuation Insights Following Breakthrough FDA Nod and Pipeline ProgressSeptember 8, 2025 | finance.yahoo.comGenmab (CPSE:GMAB) Is Up 10.3% After FDA Breakthrough for Rina-S in Endometrial Cancer – Has The Bull Case Changed?September 6, 2025 | finance.yahoo.comGenmab A/S (OTCMKTS:GNMSF) Shares Gap Up - Time to Buy?September 5, 2025 | marketbeat.comGenmab A/S (OTCMKTS:GNMSF) Share Price Crosses Above 50-Day Moving Average - Here's WhySeptember 5, 2025 | marketbeat.comGenmab A/S (GMAB)’s Epcoritamab Delivers 95% Response in LymphomaAugust 29, 2025 | uk.finance.yahoo.comGenmab A/S (GMAB) Expands Tivdak and Epkinly Commercial Push GloballyAugust 29, 2025 | uk.finance.yahoo.comGenmab A/S (OTCMKTS:GNMSF) Stock Price Passes Above Fifty Day Moving Average - Should You Sell?August 28, 2025 | marketbeat.comGenmab A/S (OTCMKTS:GNMSF) Sees Large Drop in Short InterestAugust 19, 2025 | marketbeat.comGenmab A/S (OTCMKTS:GNMSF) Shares Gap Up - Here's WhyAugust 17, 2025 | marketbeat.comGenmab Updates Articles to Boost Financial FlexibilityAugust 13, 2025 | tipranks.comGenmab A/S (OTCMKTS:GNMSF) Announces Quarterly Earnings Results, Beats Estimates By $1.43 EPSAugust 11, 2025 | marketbeat.comGenmab A/S (OTCMKTS:GNMSF) Share Price Passes Above 50 Day Moving Average - What's Next?August 7, 2025 | marketbeat.comPfizer and Genmab’s Tivdak Study: Assessing Ocular Safety in Cervical Cancer TreatmentJuly 31, 2025 | msn.comGenmab A/S (GMAB) Opens U.S. Hub in New Jersey to Drive Global GrowthJuly 25, 2025 | insidermonkey.comGenmab (GMAB) Announced New Sales Figures for DARZALEXJuly 25, 2025 | insidermonkey.comGenmab A/S (OTCMKTS:GNMSF) Shares Gap Up - What's Next?July 24, 2025 | marketbeat.comGenmab A/S (OTCMKTS:GNMSF) Shares Cross Above Fifty Day Moving Average - Should You Sell?July 19, 2025 | marketbeat.comGenmab A/S (OTCMKTS:GNMSF) Shares Pass Above Fifty Day Moving Average - Time to Sell?July 11, 2025 | marketbeat.comGenmab A/S (OTCMKTS:GNMSF) Share Price Passes Below 50 Day Moving Average - Time to Sell?July 3, 2025 | marketbeat.comGenmab Completes Share Buy-back ProgramJune 30, 2025 | tipranks.comGenmab A/S (OTCMKTS:GNMSF) Stock Crosses Above Fifty Day Moving Average - Here's What HappenedJune 25, 2025 | marketbeat.comGenmab A/S (GNMSF) Stock Price, Quote, News & Analysis - Seeking AlphaJune 24, 2025 | seekingalpha.comGenmab A/S (OTCMKTS:GNMSF) Trading Down 4.9% - Here's What HappenedJune 18, 2025 | marketbeat.comGenmab A/S Updates Articles of Association for Strategic GrowthJune 18, 2025 | tipranks.comGenmab Discloses Managerial Share Transactions in Compliance with RegulationsJune 17, 2025 | tipranks.com Get Genmab A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for GNMSF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GNMSF Media Mentions By Week GNMSF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GNMSF News Sentiment▼-0.060.54▲Average Medical News Sentiment GNMSF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GNMSF Articles This Week▼112▲GNMSF Articles Average Week Get the Latest News and Ratings for GNMSF and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Genmab A/S and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Takeda Pharmaceutical News Today argenex News Today Daiichi Sankyo News Today BeOne Medicines News Today Insmed News Today BioNTech News Today Teva Pharmaceutical Industries News Today Genmab A/S News Today Summit Therapeutics News Today Dr. Reddy's Laboratories News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:GNMSF) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersThis soon could be the most precious company in AmericaCurrently, a brand-new, all-American factory outside San Antonio is becoming the most significant site in the ...True Market Insiders | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredIs Nvidia about to Trigger Another 150X Opportunity?Nvidia gave investors a chance to make more than 150 times their money with its AI chips, known as graphics pr...InvestorPlace | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genmab A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Genmab A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
